With depression still at higher-than-normal levels, a news study finds the door is open for pharma companies to reach out to patients especially on social media. (Credit: Shutterstock)

Men­tal health cri­sis fol­lows Covid pan­dem­ic in US, but phar­ma miss­ing con­nec­tions to younger gen­er­a­tions, study finds

The of­ten-dis­cussed men­tal health cri­sis pre­cip­i­tat­ed by the pan­dem­ic isn’t re­solv­ing — de­spite ex­pec­ta­tions that when re­stric­tions lift­ed, so would de­pres­sion. In­stead, it may be get­ting worse, ac­cord­ing to a new study from CMI Me­dia Group.

Men­tions of de­pres­sion on so­cial me­dia jumped from 5,800 in May 2021 to 7,800 in April 2022. While that could in­clude a more open at­ti­tude to dis­cus­sions — which is a good thing — it al­so points to what in­sid­ers in the health­care com­mu­ni­ty an­tic­i­pat­ed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.